Archive | September 2023

QUOTE FOR THE WEEKEND:

“Benign paroxysmal positional vertigo (BPPV) is the most common vertiginous disorder in the community. The cardinal symptom is sudden vertigo induced by a change in head position: turning over in bed, lying down in bed (or at the dentist or hairdresser), looking up, stooping, or any sudden change in head position. There is a wide spectrum of severity. Mild symptoms are inconsistent positional vertigo. Moderate symptoms are frequent positional attacks with disequilibrium between. When severe, vertigo is provoked by most head movements, giving an impression of continuous vertigo. The symptoms can last for days, weeks, months, or years, or be recurrent over many years.”

National Library of Medicine (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144715/)

QUOTE FOR FRIDAY:

“BPPV is estimated to affect roughly 50% of all people at some time in their lives and becomes progressively more common with age. During periods when attacks are not occurring, the diagnosis is made from the characteristic history and by the exclusion of other disorders that can cause similar dizzy symptoms. When attacks are occurring, the Hallpike positional test is diagnostic. In the commonest form of BPPV the Hallpike test is positive (i.e. induces vertigo and nystagmus) when the affected ear is down most. Up to 10% of cases may involve both ears.”

Menieres Society (https://www.menieres.org.uk/information-and-support/symptoms-and-conditions/bppv)

QUOTE FOR THURSDAY:

“Benign paroxysmal positional vertigo (BPPV) is the most common cause of peripheral vertigo, accounting for over half of all cases. According to various estimates, a minimum of 20% of patients presenting to the provider with vertigo have BPPV. However, this figure could be an underestimation as BPPV is frequently misdiagnosed. It is crucial to distinguish BPPV from other causes of vertigo as the differential diagnosis includes a spectrum of disease processes ranging from benign to life-threatening. Because of the misleading and vague term ‘dizziness’ that patients commonly use, the provider must pin down what every patient means by it. It can be often achieved by asking the patient to describe what they are feeling without the use of the word ‘dizziness.

Barany first described BPPV in 1921. At that time, characteristic vertigo and nystagmus associated with postural changes were linked to the otolithic organs. In 1952, Dix and Hallpike, during their provocative testing, further described classic nystagmus and moved on to explain that the location of the pathology was the ear proper.”

National Library of Medicine (https://www.ncbi.nlm.nih.gov/books/NBK470308/)

QUOTE FOR WEDNESDAY:

“In 2021, an estimated 12.3 million adults seriously thought about suicide, 3.5 million made a plan, and 1.7 million attempted suicide. Many factors can increase the risk for suicide or protect against it. Suicide is connected to other forms of injury and violence. For example, people who have experienced violence, including child abuse, bullying, or sexual violence have a higher suicide risk. Being connected to family and community support and having easy access to healthcare can decrease suicidal thoughts and behaviors. So know there is a way to PREVENTION!”.

Centers for Disease Control – CDC (https://www.cdc.gov/suicide/facts/index.html)

Suicide in America

  

Suicide is a major public health problem and a leading cause of death in the United States. The effects of suicide go beyond the person who acts to take his or her life: it can have a lasting effect on family, friends, and communities. This fact sheet, developed by the National Institute of Mental Health (NIMH), can help you, a friend, or a family member learn about the signs and symptoms, risk factors and warning signs, and ongoing research about suicide and suicide prevention.

What Is Suicide?

Suicide is when people direct violence at themselves with the intent to end their lives, and they die because of their actions. It’s best to avoid the use of terms like “committing suicide” or a “successful suicide” when referring to a death by suicide as these terms often carry negative connotations.

A suicide attempt is when people harm themselves with the intent to end their lives, but they do not die because of their actions.

Who Is at Risk for Suicide?

Suicide does not discriminate. People of all genders, ages, and ethnicities can be at risk.

The main risk factors for suicide are:

  • A prior suicide attempt
  • Depression and other mental health disorders
  • Substance abuse disorder
  • Family history of a mental health or substance abuse disorder
  • Family history of suicide
  • Family violence, including physical or sexual abuse
  • Having guns or other firearms in the home
  • Being in prison or jail
  • Being exposed to others’ suicidal behavior, such as a family member, peer, or media figure
  • Medical illness
  • Being between the ages of 15 and 24 years or over age 60

Even among people who have risk factors for suicide, most do not attempt suicide. It remains difficult to predict who will act on suicidal thoughts.

Are certain groups of people at higher risk than others?

According to the Centers for Disease Control and Prevention (CDC), men are more likely to die by suicide than women, but women are more likely to attempt suicide. Men are more likely to use more lethal methods, such as firearms or suffocation. Women are more likely than men to attempt suicide by poisoning.

Also per the CDC, certain demographic subgroups are at higher risk. For example, American Indian and Alaska Native youth and middle-aged persons have the highest rate of suicide, followed by non-Hispanic White middle-aged and older adult males. African Americans have the lowest suicide rate, while Hispanics have the second lowest rate. The exception to this is younger children. African American children under the age of 12 have a higher rate of suicide than White children. While younger preteens and teens have a lower rate of suicide than older adolescents, there has been a significant rise in the suicide rate among youth ages 10 to 14. Suicide ranks as the second leading cause of death for this age group, accounting for 425 deaths per year and surpassing the death rate for traffic accidents, which is the most common cause of death for young people.

Why do some people become suicidal while others with similar risk factors do not?

Most people who have the risk factors for suicide will not kill themselves. However, the risk for suicidal behavior is complex. Research suggests that people who attempt suicide may react to events, think, and make decisions differently than those who do not attempt suicide. These differences happen more often if a person also has a disorder such as depression, substance abuse, anxiety, borderline personality disorder, and psychosis. Risk factors are important to keep in mind; however, someone who has warning signs of suicide may be in more danger and require immediate attention.

What Are the Warning Signs of Suicide?

The behaviors listed below may be signs that someone is thinking about suicide.

  • Talking about wanting to die or wanting to kill themselves
  • Talking about feeling empty, hopeless, or having no reason to live
  • Planning or looking for a way to kill themselves, such as searching online, stockpiling pills, or newly acquiring potentially lethal items (e.g., firearms, ropes)
  • Talking about great guilt or shame
  • Talking about feeling trapped or feeling that there are no solutions
  • Feeling unbearable pain, both physical or emotional
  • Talking about being a burden to others
  • Using alcohol or drugs more often
  • Acting anxious or agitated
  • Withdrawing from family and friends
  • Changing eating and/or sleeping habits
  • Showing rage or talking about seeking revenge
  • Taking risks that could lead to death, such as reckless driving
  • Talking or thinking about death often
  • Displaying extreme mood swings, suddenly changing from very sad to very calm or happy
  • Giving away important possessions
  • Saying goodbye to friends and family
  • Putting affairs in order, making a will

Do People Threaten Suicide to Get Attention?

Suicidal thoughts or actions are a sign of extreme distress and an alert that someone needs help. Any warning sign or symptom of suicide should not be ignored. All talk of suicide should be taken seriously and requires attention. Threatening to die by suicide is not a normal response to stress and should not be taken lightly.

If You Ask Someone About Suicide, Does It Put the Idea Into Their Head?

Asking someone about suicide is not harmful. There is a common myth that asking someone about suicide can put the idea into their head. This is not true. Several studies examining this concern have demonstrated that asking people about suicidal thoughts and behavior does not induce or increase such thoughts and experiences. In fact, asking someone directly, “Are you thinking of killing yourself,” can be the best way to identify someone at risk for suicide.

What Should I Do if I Am in Crisis or Someone I Know Is Considering Suicide?

If you or someone you know has warning signs or symptoms of suicide, particularly if there is a change in the behavior or a new behavior, get help as soon as possible.

Often, family and friends are the first to recognize the warning signs of suicide and can take the first step toward helping an at-risk individual find treatment with someone who specializes in diagnosing and treating mental health conditions. If someone is telling you that they are going to kill themselves, do not leave them alone. Do not promise anyone that you will keep their suicidal thoughts a secret. Make sure to tell a trusted friend or family member, or if you are a student, an adult with whom you feel comfortable. You can also contact the resources noted below.

Leading Cause of Death in the United States (2016)
Data Courtesy of CDC
Select Age Groups
Rank 10-14 15-24 25-34 35-44 45-54 55-64 All Ages
1 Unintentional
Injury
847
Unintentional
Injury
13,895
Unintentional
Injury
23,984
Unintentional
Injury
20,975
Malignant
Neoplasms
41,291
Malignant
Neoplasms
116,364
Heart
Disease
635,260
2 Suicide
436
Suicide
5,723
Suicide
7,366
Malignant
Neoplasms
10,903
Heart
Disease
34,027
Heart
Disease
78,610
Malignant
Neoplasms
598,038
3 Malignant
Neoplasms
431
Homicide
5,172
Homicide
5,376
Heart
Disease
10,477
Unintentional
Injury
23,377
Unintentional
Injury
21,860
Unintentional
Injury
161,374
4 Homicide
147
Malignant
Neoplasms
1,431
Malignant
Neoplasms
3,791
Suicide
7,030
Suicide
8,437
      CLRD
17,810

QUOTE FOR TUESDAY:

“A 12 lead EKG is a painless and noninvasive test that measures your heart’s electrical efficiency as it beats. As one of the fastest informational or diagnostic heart tests available, EKG testing can usually be completed in just five minutes.  To conduct an EKG test, our team attaches up to 12 small, flat, sticky patches called electrodes at various points on your chest, arms, and legs. The electrodes are connected to a monitor that registers your heart’s electrical activity over the course of the exam.Their is another device called telemetry monitoring that can be done in the hospital or even at home through what we call a holter monitor.  Both telemetry monitoring or holter monitoring are done with a 5 leads or electrodes on the upper chest (R and L side), mid chest (just under nipple line close to where the heart lies) and 2 more leads or electrodes just below the rib cage (on the R and L side). This holter device can be done for a couple of days and returned to the MD’s office.  An EKG or holter monitor test results that tell us whether electrical waves pass through your heart at a normal rate, faster than normal, slower than normal, or in an irregular pattern. Results that are fast, slow, or irregular, may be a sign that your heart is weak or overworked, or that it has some kind of structural (size or shape) abnormality.”

ECCA (https://eccacardiologists.com/2020/03/03/what-an-ekg-test-can-tell-your-doctor-about-your-heart/)

What cardiac rhythms tells your doctor about your heart!

Heart Beat symbol design element

Why cardiac monitoring can be vital important in quickly telling the doctors and nurses very important messages in what is going on with the patient’s heart and overall condition problem (Example A Myocardial Infarction or even to Cardiac Arrest).

Cardiac monitoring is a great way for doctors to understand a patients’ overall heart health, and can provide enough information to quickly and accurately helping the doctor or nurse as a diagnostic tool based on several details within a heart rhythm. While each arrhythmia monitoring device is a little different, these details are essential in diagnosing any underlying and potentially life-threatening events.

Your heart can have the best rhythm it can be in called Normal Sinus Rhythm which is a rhythm that is produced by the sinus node (SA node) that is the human pacemaker of the heart in out right upper atrium.  It starts a impulse (think of it as a message) that starts from the SA node and goes down the right atrium across to the left atrium (the upper chambers of the heart) with contiuing to send both impulses down to the bottom chambers of the heart which we call Ventricles creating the sound we all know the heart make called “lub dub”. This sound is creating when our heart valves open and close between the heart to allow complete fill up and release for the cardiac filling of our blood from top chambers to bottom and out of the heart to our circulation to send oxygenation out to all our tissues from feet to brain and back to lungs where our red blood cells carry the oxygen to tissues but take carbon dioxide back to the lungs for an exchange of new oxygen we breath in to exchange the carbon dioxide for new oxygen in the red blood cells and is send to the heart sent out back to our circulation to keep our body tissues oxygenated.  Without oxygenation that would be red blood cell starvation resulting into death for the human body.

There are times the SA node does not work for some reasons which causes the heart to start sending impulses from areas lower than where the SA node sits in the heart, in the upper right area of the heart.  Now some rhythms under the SA node can live a normal life with being checked up by a Cardiologist preferably or a Primary Care Doctor but know the Cardiologist will probably pick up before any other MD, if numerous years of experience.

Here is the basics to know about telemetry monitoring and your heart rate (also known as pulse):

1. Arrhythmias: Ambulatory heart monitors can be assigned for short-term use (24 to 72 hours) or for long-term use (up to 30 days or more) depending on what your doctor needs to know. Many cardiac monitoring devices record the ups and downs of your heartbeat to determine the presence of any irregularities in your rhythm that could be associated with an arrhythmia that’s new but possibly easily treatable or even curable to dangerous possibly or any underlying conditions.  There’s a device that we call holter monitor.  This device is what you wear for days and bring back to your doctor with leaving on 24hrs or  couple of days till you take off when the MD tells you too.  Than there is continuous telemetry monitoring in the hospital that records on the unit computer the patient usually is on.  This the MD reviews when you come back to his office with the holter monitor or the MD reviews daily or more when in the hospital.  This helps direct the MD in your care since it is a diagnostic tool for him or her.

2. Heart Rate: Your heart rate is the number of times your heart beats per unit of time, and can vary depending on your activities, sleep, and even what you eat. If it gets too low or too high when performing a specific activity, it’s essential that your doctor knows about it. A normal resting heart rate for adults ranges from 60 to 99 beats a minute.  The lower the better but usually not more than 50 if you have been in the heart rate or pulse of 50’s all your life due to being an athelete (some even in there 40’s) but if you have symptoms like dizzy, weakness, change in mental status, chest pain/discomfort, to indigestion that just won’t go away SEE THE MD; especially if the HR or pulse rate is new in a low rate that you are in.

3. P-wave analysis: On the telemetry monitor what MD’s, nurses and even technicians see are rhythm waves that is represented by names for each aspect of the wave we study.  The first wave if in normal sinus rhythm or some type of sinus rhythm we see what we call a p-wave represents the spread of electrical activity over the atrium, and normally lasts less than 0.11 seconds that derived from the SA node.  This is how sinus rhythms got their names.  An abnormally long p-wave occurs when it takes extra time for the electrical wave to reach the entire atrium.  This is the area right before that bigger wave we call QRS wave.   The prolongation for the PR interval signifies usually some type of AV block.  This occurs down at the valves between the upper chambers (atriums) and lower chambers (ventricles).  Ventricle rhythms means their is no impulse going through the atrium or we would see a atrium rhythm so now the ventricles take over to make a rhythm showing Ventricular Rhythms.  These are dangerous rhythms.

4. Morphology: This refers to the form of cardiac rhythms and how they differ depending on underlying conditions. The morphology of a heart rhythm can be observed as a series of deflections away from the baseline of an ECG, and can vary if you have any type of condition that could affect your heart  (Let’s say heart failure to even drugs like Cocaine which is famous for speeding the heart up commonly know for putting patients in atrial RVR; meaning atrial fibrillation but at a high heart rate in the atriums putting your pulse at a HR of 150 to 250 and can lead to a heart attack.

Cardiac and arrhythmia monitoring solutions means that you can start treatment much sooner. Your heart monitor provides your physician with data necessary for diagnoses for a wide range of populations including geriatric, diabetic and pediatric patients, all age groups.

QUOTE FOR THE WEEKEND:

“Childhood Cancer Awareness Month (CCAM) is recognized every September by childhood cancer organizations around the world.  Each year in the U.S., an estimated 15,780 are diagnosed with cancer, regarding children aged 0-19 are diagnosed with cancer.   20% of the children diagnosed with cancer in the U.S. will not survive.  Cancer remains the #1 cause of death for childen in America. Every 3 minutes a family hears the devastating words that their child has been diagnosed with cancer. ”

American Childhood Cancer Organization (https://www.acco.org/childhood-cancer-awareness-month/)

 

QUOTE FOR FRIDAY:

“The diagnosis of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia is usually challenging due to the lack of specific morphologic, immunophenotypic, or chromosomal changes. This lack makes the differentiation of this disease entity from other small B cell lymphomas based on exclusion. Symptoms can be classified into two categories: neoplasmic organ involvement and IgM paraprotein-related symptoms. Patients may present with B-related symptoms such as fever, night sweats, weight loss. Because of the frequent involvement of bone marrow, most lymphoplasmacytic lymphoma patients present with weakness and/or fatigue related to anemia. Some patients may present with the involvement of spleen, liver, and other extranodal sites, including skin, stomach, and bowel. As a rule, the diagnosis of lymphoplasmacytic lymphoma should be considered in elderly individuals with unexplained weakness, bleeding, neurological deficits, neuropathies, and visual difficulties.”

National Library of Medicine (https://www.ncbi.nlm.nih.gov/books/NBK513356/)

Part II Waldenstrom’s Macroglobulinemia (WM) & Lymphoplasmacytic Lymphoma (LPL)

 

Waldenstrom’s macroglobulinemia is named for the Swedish physician Jan Gosta Waldenström (1906-1996), who in 1944 identified a rare condition in which two patients experienced a thickening of their blood serum, bleeding of the mouth, nose, and blood vessels of the retina, low red blood cell and platelet counts, high erythrocyte sedimentation rates, and lymph node involvement. Bone marrow biopsies showed an excess of lymphoid cells and bone X-rays were normal, excluding a diagnosis of multiple myeloma. Both patients also had a large amount of a single unknown blood protein with an extremely high molecular weight, a “macro” globulin. We now know this globulin as IgM.

Waldenström macroglobulinemia (WM) is an indolent (slow-growing) subtype of non-Hodgkin lymphoma that affects small lymphocytes (white blood cells).
Under the microscope, WM cells have characteristics of both B-lymphocytes and plasma cells, and they are called lymphoplasmacytic cells. For that reason, WM is classified as a type of non-Hodgkin’s lymphoma called lymphoplasmacytic lymphoma (LPL).
As a result of proliferation in the bone marrow and other sites, the lymphoplasmacytic cells of WM may interfere with normal functioning. In the bone marrow where blood cells are produced, the WM cells “crowd out” the normal blood cells and may lead to a reduction in normal blood counts. How this works is the WM cells grow mainly in the bone marrow, where they can crowd out the normal cells (that grow in our bone marrow). This can lead to low levels of red blood cells (called anemia), which can make people feel tired and weak.; WM effects the lymph nodes and other organs (ex. Spleen), the WM cells may lead to enlargement of these structures and other complications.

The over-production of IgM may also cause many of the symptoms associated with the disease. IgM is a large antibody and tends to make the blood thicker than normal, a condition called hyperviscosity. Unlike normal antibodies that fight infection, the IgM produced by WM cells has no useful function. Sometimes the IgM may incorrectly recognize the body’s tissues as “foreign” and attach to them, causing inflammation and injury.

What are the symptoms of this condition?                      

People with Waldenstrom’s macroglobulinemia may experience the following symptoms or signs. Sometimes, people with Waldenstrom’s macroglobulinemia do not have any of these changes. Or, the cause of a symptom may be a different medical condition that is not cancer.

  • Fatigue
  • Unexplained weight loss
  • Enlarged lymph nodes or spleen
  • Numbness, weakness or other nervous system problems, pain in the hands or feet, sometimes called peripheral neuropathy
  • Abdominal swelling and diarrhea
  • Weakness and shortness of breath
  • Infections
  • Raised pink or flesh-colored lesions on the skin
  • Changes in the color of the fingertips when exposed to cold
  • Changes in vision, which may include blurry vision or “double” vision

May signal a more aggressive cancer:

  • Unexplained weight loss
  • Unexplained fever
  • Heavy sweating, especially at night, which may drench one’s nightclothes or sheets on the bed.
  • Severe and/or extensive skin itchiness

How is it diagnosed?

For starters LAB TESTS:

WM might be suspected if your doctor finds you have low blood cell counts or unusual protein levels on blood tests. If so, your doctor may order a blood test called serum protein electrophoresis to find out what the abnormal proteins are. It is usually only after these tests are done that a biopsy of either the bone marrow or a lymph node is considered.

Simply a CBC Complete blood count, that measures the levels of red blood cells, white blood cells, and platelets. If lymphoma cells occupy too much of the bone marrow, these levels will be low.

Quantitative Immunoglobulins – This test measures the levels of the different antibodies (immunoglobulins) in the blood – IgA, IgE, IgG, and IgM – to see if any are abnormally high or low. In WM the level of IgM is high but the IgG level is often low.

Electrophoresis

The abnormal immunoglobulin made in WM is an IgM antibody. This antibody is monoclonal, meaning that it is many copies of the exact same antibody. Serum protein electrophoresi  s (SPEP) is a test that measures the total amount of immunoglobulins in the blood and finds any monoclonal immunoglobulin. Another test, such as immunofixation or immunoelectrophoresis, is then used to determine the type of antibody that is abnormal (IgM or some other type).

Finding a monoclonal IgM antibody in the blood is needed to diagnose WM. This abnormal protein in WM is known by many different names, including monoclonal immunoglobulin M, IgM protein, IgM spike, IgM paraprotein, M protein, and M-spike. High levels of other types of monoclonal immunoglobulins, like IgA or IgG, are seen in different disorders (like multiple myeloma and some other lymphomas).

Sometimes pieces of the IgM protein are excreted by the kidneys into the urine. These proteins can be detected with a test called urine protein electrophoresis (or UPEP).

Viscosity

Viscosity is a measure of how thick the blood is. If the IgM level is too high, the blood will become thick (viscous) and can’t flow freely (think about pouring honey compared to pouring water).

Cryocrit

This test measures the blood levels of cryoglobulins (proteins that clump together in cool temperatures and can block blood vessels).

Cold agglutinins

Cold agglutinins are antibodies that attack and kill red blood cells, especially at cooler temperatures. These dead cells can then build up and block blood vessels. A blood test can be used to detect these antibodies.

Beta-2 microglobulin (β2M)

This test measures another protein made by the cancer cells in WM. This protein itself doesn’t cause any problems, but it’s a useful indicator of a patient’s prognosis (outlook). High levels of β2M are linked with a worse outlook.

Biopsies

The symptoms of WM and NHL are not distinctive enough for a doctor to know for certain if person has one of them, based on symptoms alone. Most symptoms can also be caused by non-cancerous problems like infections or by other kinds of cancers. Blood tests can help point to the correct diagnosis, but a biopsy (removing samples of affected tissue to look at under a microscope) is the only way to be sure. Several types of biopsies might be used.

Bone marrow aspiration and biopsy

This is the most important type of biopsy for WM, and is needed to confirm the diagnosis. It can be done at the doctor’s office or at the hospital.

The bone marrow aspiration and biopsy are usually done at the same time. The samples are taken from the back of the pelvic (hip) bone, although in some cases they may be taken from the sternum (breast bone) or other bones.

In bone marrow aspiration, you lie on a table (either on your side or on your belly). The doctor cleans the skin over the hip and then numbs the area and the surface of the bone by injecting a local anesthetic. This may briefly sting or burn. A thin, hollow needle is then inserted into the bone, and a syringe is used to suck out a small amount of liquid bone marrow. Even with the anesthetic, most patients still have some brief pain when the marrow is removed.

A bone marrow biopsy is usually done just after the aspiration. A small piece of bone and marrow is removed with a slightly larger needle that is pushed down into the bone. This may also cause some brief pain.

Once the biopsy is done, pressure is applied to the site to help stop any bleeding. There will be some soreness in the biopsy area when the numbing medicine wears off. Most patients can go home right after the procedure.

The bone marrow samples are then sent to a lab, where they are tested to see if they have lymphoma cells (see below). For a diagnosis of WM, at least 10% of the cells in the bone marrow must be lymphoplasmacytoid lymphoma cells.

Fine needle aspiration (FNA) biopsy

In an FNA biopsy, the doctor uses a very thin, hollow needle with a syringe to withdraw a small amount of tissue from a tumor or lymph node. This type of biopsy is useful for sampling lymph nodes to see if they are enlarged because of cancer or another cause such as infection. FNA can help diagnose some lymphomas, but WM is usually diagnosed with a bone marrow biopsy instead.

For an FNA on an enlarged node near the surface of the body, the doctor can aim the needle while feeling the node. If the enlarged node (or tumor) is deep inside the body, the needle can be guided while it is seen on a computed tomography (CT) scan or ultrasound (see the descriptions of imaging tests later in this section).

The main advantage of FNA is that it does not require surgery and can often be done in a doctor’s office. The main drawback is that in some cases it might not get enough tissue to make a definite diagnosis of lymphoma. However, advances in lab tests (discussed later in this section) and the growing experience of many doctors with FNA have improved the accuracy of this procedure.

Excisional or incisional biopsy

For these types of biopsies, a surgeon cuts through the skin to remove an entire lymph node or tumor (excisional biopsy) or a just a small part of a large tumor or lymph node (incisional biopsy). These biopsies are rarely needed in people with WM because the diagnosis is usually made with a bone marrow biopsy. They are used more often for other types of lymphoma.

If the area to be biopsied is near the skin surface, this can be done using local anesthesia (numbing medicine). If the area is inside the chest or abdomen, general anesthesia or deep sedation is used (where the patient is asleep). These types of biopsies almost always provide enough tissue to diagnose the exact type of lymphoma.

Fat pad fine needle aspiration

This type of biopsy may be used in some people with WM to check for amyloid. In this procedure, a thin, hollow needle with a syringe attached is inserted into an area of fat (usually under the skin of the abdomen/belly). A small amount of fat is removed and sent to the lab for testing.

Lab tests on biopsy specimens

All biopsy specimens are looked at under a microscope by a pathologist – a doctor with special training in using lab tests to diagnose diseases. In some cases, a hematopathologist, a doctor with further training in diagnosing blood and lymph node diseases, might also look at the biopsy. The doctors look at the size and shape of the cells and how the cells are arranged. Sometimes just looking at the cells doesn’t provide a clear answer, so other lab tests are needed.

Immunohistochemistry

In this test, a part of the biopsy sample is treated with special man-made antibodies that attach to cells only if they contain specific molecules. These antibodies cause color changes, which can be seen under a microscope. This test may help tell different types of lymphoma from one another and from other diseases.

Flow cytometry

In this test, cells are treated with special man-made antibodies. Each antibody sticks only to certain types of cells. The cells are then passed in front of a laser beam. If the cells now have antibodies attached to them, the laser will make them give off light, which is measured and analyzed by a computer.

This is the most common test for immunophenotyping – classifying lymphoma cells according to the substances (antigens) on their surfaces. Different types of lymphocytes have different antigens on their surface. These antigens also change as each cell matures.

This test can help show whether a lymph node is swollen because of lymphoma, some other cancer, or a non-cancerous disease. It has become very important in helping doctors determine the exact type of lymphoma so they can select the best treatment.

Cytogenetics

Doctors use this technique to look at the chromosomes (long strands of DNA) inside lymphoma cells. Cells (usually from the bone marrow) are first grown in the lab. Then the chromosomes are stained and looked at under a microscope. Because it takes time for the cells to start dividing, this test can take weeks.

In some lymphomas, the cells may have too many chromosomes, too few chromosomes, missing parts of chromosomes (called deletions), or other abnormalities. These changes can help identify the type of lymphoma. In WM, deletions are the most common type of chromosome change.

Molecular genetic tests

Molecular tests such as fluorescent in situ hybridization (FISH) and polymerase chain reaction (PCR) are not usually needed to diagnose WM, but they are sometimes used to diagnose other types of NHL. These tests look at the cells’ DNA without having to grow the cells in the lab first. The tests can give results in less time than cytogenetics and can be done on cells from different sources (like lymph nodes, blood, and bone marrow). They are generally used to look for specific chromosome or gene changes, not just any change.

Imaging tests

Imaging tests use x-rays, magnetic fields, sound waves, or radioactive particles to produce pictures of the inside of the body. These tests are not needed to diagnose WM, but one or more of them might be done to help show the extent of the disease in the body.

Chest x-ray

An x-ray might be done to look at the chest for enlarged lymph nodes.

Computed tomography (CT) scan

The CT scan uses x-rays to make detailed cross-sectional images of your body. Unlike a regular x-ray, CT scans can show the detail in soft tissues (such as internal organs). This scan can help show if any lymph nodes or organs in your body are enlarged. CT scans are useful for looking for signs of lymphoma in the chest, abdomen, and pelvis.

Before the test, you may be asked to drink a contrast solution and/or get an intravenous (IV) injection of a contrast dye to better outline abnormal areas in the body. You might need an IV line through which the contrast dye is injected. The injection can cause some flushing (a feeling of warmth, especially in the face). Some people are allergic to the dye and get hives or a flushed feeling or, rarely, have more serious reactions like trouble breathing and low blood pressure. Be sure to tell the doctor if you have any allergies (especially iodine or shellfish) or have ever had a reaction to any contrast material used for x-rays. Medication can be given to help prevent and treat allergic reactions.

A CT scanner has been described as a large donut, with a narrow table that slides in and out of the middle opening. You need to lie still on the table while the scan is being done. CT scans take longer than regular x-rays, and some people might feel a bit confined by the ring while the pictures are being taken.

CT-guided needle biopsy: CT scans can also be used to guide a biopsy needle into a suspicious area. For this procedure, the patient lies on the CT scanning table while the doctor moves a biopsy needle through the skin and toward the area. CT scans are repeated until the needle is in the right place. A biopsy sample is then removed and sent to the lab to be looked at under a microscope.

Magnetic resonance imaging (MRI) scan

Like CT scans, MRI scans make detailed images of soft tissues in the body. But MRI scans use radio waves and strong magnets instead of x-rays. This test is rarely used in WM, but if your doctor is concerned about the brain or spinal cord, MRI is very useful for looking at these areas.

Sometimes a contrast material is injected into a vein to make some structures clearer. This contrast is not the same as the contrast used for CT scans, but allergic reactions can still occur. Again, medicine can be given to prevent and treat allergic reactions.

MRI scans take longer than CT scans – often up to an hour. You may have to lie inside a narrow tube, which is confining and can upset some people. Newer, more open MRI machines might be another option. The machine makes loud buzzing and clicking noises that some people find disturbing. Some places provide headphones or earplugs to help block this noise out.

Ultrasound

Ultrasound uses sound waves and their echoes to make pictures of internal organs or masses.

Ultrasound can be used to look at lymph nodes near the surface of the body or to look inside your abdomen for enlarged lymph nodes or organs such as the liver, spleen, and kidneys. (It can’t be used to look at organs or lymph nodes in the chest because the ribs block the sound waves.) It is sometimes used to help guide a biopsy needle into an enlarged lymph node.

For this test, a small, microphone-like instrument called a transducer is placed on the skin (which is first lubricated with a gel). It gives off sound waves and picks up the echoes as they bounce off the organs. A computer then converts the echoes into a black and white image on a screen.

This is an easy test to have, and it uses no radiation. For most ultrasounds, you simply lie on a table, and a technician moves the transducer over the part of your body being looked at.

Positron emission tomography (PET) scan

For a PET scan, a radioactive sugar (known as FDG) is injected into the blood. (The amount of radioactivity used is very low and will pass out of the body in a day or so.) Because cancer cells in the body grow quickly, they absorb large amounts of the sugar. You then lie on a table in the PET scanner for about 30 minutes while a special camera creates a picture of areas of radioactivity. The picture is not detailed like a CT or MRI scan, but it can provide helpful informa- tion about your whole body.

PET scans can help tell if an enlarged lymph node contains lymphoma or not. It can also help spot small areas that might be lymphoma, even if the area looks normal on a CT scan. These tests can be used to tell if a lymphoma is responding to treatment. They can also be used after treatment to help decide whether an enlarged lymph node still contains lymphoma or is merely scar tissue.

Many medical centers now use a machine that combines the PET scan with a CT scan (PET/CT scan). This lets the doctor compare areas of higher radioactivity on the PET scan with the more detailed appearance of that area on the CT scan.

Questions you might be thinking and would like answered.

Should I get a second opinion? If so when?

It is not unusual for newly diagnosed patients or patients needing treatment to get a second opinion from a recognized
WM expert or from a hematologist/oncologist who
has an interest and experiencewith the diagnosis and treatment of
WM. WM is a rare disease and as a result, many hematologist/oncologists may have little experience dealing with WM patients.  The IWMF newsletter, the Torch, has published an article on this subject, called “Should I Get a Second Opinion,” written by Morie A. Gertz MD, MACP. You can find this article at
www.iwmf.com/sites/default/files/docs/publications/Gertz5Second.pdf.
How do I find a good doctor for a second opinion?
Generally speaking, large teaching hospitals see more WM patients and have staff physicians more experienced with
WM. The IWMF website maintains a list of
physicians who have an interest and experience in the management and treatment of WM www.iwmf.com/get-support/directory-wm-
physicians.
 
When should I get treatment?
Patients should be treated when they become symptomatic
or infrequently when blood tests
results pose a health risk.
To some extent, the decision to begin treatment is dependent on a particular patient’s tolerance of symptoms and how
they are affecting their quality of life. The IgM level in and of itself is not an indication for treatment.
Additional treatment indicators can be found at :www.iwmf.com/about-wm/treatment/reasons-undergo-treatment
.
Also, the IWMF newsletter, the Torch, has published an article on this subject, called “Who Needs Treatment for Waldenstrom’s
Macroglobulinemia and When?” written by Stephen M. Ansell MD, PhD. This article can be found at
www.iwmf.com/sites/default/files/docs/publications/BestOfTorch16.2Ansell.pdf.

What treatments are approved for WM?

Currently,Imbruvica (ibrutinib) is the only approved treatment
specifically for WM in the US, Israel, Canada and many European countries. Most treatments are based on results achieved for similar diseases such as follicular lymphoma, chronic lymphocytic leukemia and multiple myeloma.
There are a number of treatment options available for WM
patients, and information regarding many of them can be accessed
at www.iwmf.com/media-library/iwmf-publications.
Also, several major cancer centers have developed guidelines for WM treatment.  You can find these at www.iwmf.com/media-library/wm-medical-practice-guidelines-research.
The treatment landscape continues to evolve, with novel therapies being discovered and tested in clinical trials. For an updated list of trials, go to the US government website, www.clinicaltrials.gov
which contains all US trials and trials in many other countries.
What should I do to protect my immune system?
Wash your hands frequently and avoid touching your hands to your face, especially during cold and flu season. Keep up to date on your flu and pneumonia vaccinations. Eat a healthy, well-balanced diet and get the proper amount of sleep. Avoid close contact with people who are exhibiting obvious symptoms of colds, flu, or other diseases. Be sure to washraw fruits and vegetables before eating and make sure that meat and seafood are cooked to the proper temperature.
These are all common sense things that everyone should do, no matter their state of health but especially if your immune system is down.
Will I still be able to travel?
You should still be able to travel, but possibly with some limitations or additional precautions. Enclosed places like
airplanes, crowded airports, and public transportation are sources of infection, especially during cold and flu season. If your disease is progressing to a point where you require treatment, or if you are currently on treatment that can adversely affect your immune system, you should ask your hematologist/oncologist if any travel
restrictions arenecessary.  Consultation with your physicianis suggested if you are planning to travel to unusual or exotic destinations where specific disease alerts might be in effect or where additional vaccinations are required.
Again-its reinforced, remember to keep up-to-date on your recommended vaccinations (with consulting your MD first to check if there would be any contraindications due to the disease and what degree this illness has put on your immunity system) and exercise. Again, common sense by washing your hands frequently and watching your diet in areas that are prone to food-and water-borne diseases.
How often should I see my hematologist/oncologist?
This depends greatly on your disease status or whether you are receiving treatment. If you have smoldering WM and are stable, you may not need to see your hematologist/oncologist more than a few times a year. If you are newly diagnosed or have progressing disease, your hematologist/oncologist willwant to follow you at more frequent intervals, perhaps once every 2-3 months. If you are currently being treated, your hematologist/oncologist may choose to monitor you even more frequently during this period because some treatments can cause side effects, which need to be recognized early and managed appropriately.
It’s advised that you consult with your hematologist/oncologist, they would know the best.
References for Part I and II Blood Cancer Awareness striveforgoodhealth would like to thank which were:
1. International Waldenstrom’s Macroglobulinemia Foundation
 https://www.iwmf.com/WhatisWM.htm
2. Leukemia and Lymphoma Society
3. American Cancer Society
4.Resident Short Review LPL and WM by Nadia Naderi, MD; David T. Yang, M.